SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Murat Emre, Paul J. Ford, Başar Bilgiç, Ergun Y. Uç, Cognitive impairment and dementia in Parkinson's disease: Practical issues and management, Movement Disorders, 2014, 29, 5
  2. 2
    Dag Aarsland, John-Paul Taylor, Daniel Weintraub, Psychiatric issues in cognitive impairment, Movement Disorders, 2014, 29, 5
  3. 3
    B. Guarnieri, M. Musicco, P. Caffarra, F. Adorni, I. Appollonio, D. Arnaldi, A. Bartoli, E. Bonanni, U. Bonuccelli, C. Caltagirone, G. Cerroni, L. Concari, F. I. I. Cosentino, S. Fermi, R. Ferri, G. Gelosa, G. Lombardi, S. Mearelli, F. Nobili, S. Passero, R. Perri, R. Rocchi, P. Sucapane, G. Tognoni, S. Zabberoni, S. Sorbi, Recommendations of the Sleep Study Group of the Italian Dementia Research Association (SINDem) on clinical assessment and management of sleep disorders in individuals with mild cognitive impairment and dementia: a clinical review, Neurological Sciences, 2014,

    CrossRef

  4. 4
    Eugenia Sinita, David Coghill, The use of stimulant medications for non-core aspects of ADHD and in other disorders, Neuropharmacology, 2014,

    CrossRef

  5. 5
    Lynn Marie Trotti, Donald L. Bliwise, Treatment of the Sleep Disorders Associated with Parkinson’s Disease, Neurotherapeutics, 2014, 11, 1, 68

    CrossRef

  6. 6
    A. Jennifer Morton, Circadian and sleep disorder in Huntington's disease, Experimental Neurology, 2013, 243, 34

    CrossRef

  7. 7
    Aleksandar Videnovic, Diego Golombek, Circadian and sleep disorders in Parkinson's disease, Experimental Neurology, 2013, 243, 45

    CrossRef

  8. 8
    Thomas Müller, Current status of safinamide for the drug portfolio of Parkinson’s disease therapy, Expert Review of Neurotherapeutics, 2013, 13, 9, 969

    CrossRef

  9. 9
    Martin McElhiney, Judith Rabkin, Wilfred Van Gorp, Richard Rabkin, Effect of armodafinil on cognition in patients with HIV/AIDS and fatigue, Journal of Clinical and Experimental Neuropsychology, 2013, 35, 7, 718

    CrossRef

  10. 10
    ROSA QUELHAS, Psychiatric Care in Parkinson’s Disease, Journal of Psychiatric Practice, 2013, 19, 2, 118

    CrossRef

  11. You have free access to this content11
    J. J. Ferreira, R. Katzenschlager, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, A. Schapira, A. Berardelli, W. H. Oertel, Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  12. 12
    T. Mollayeva, C.M. Shapiro, Encyclopedia of Sleep, 2013,

    CrossRef

  13. 13
    Pouya Movahed, M Mitra, K Chaudhuri, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  14. 14
    Pouya Movahed, M. Tanya Mitra, K. Ray Chaudhuri, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  15. 15
    Vanessa A. Garcia, Gabriela Matos, Sergio Tufik, Fulvio A. Scorza, Esper A. Cavalheiro, Nadja Schröder, Monica L. Andersen, Demystifying the effect of modafinil in epilepsy, Epilepsy & Behavior, 2012, 24, 2, 287

    CrossRef

  16. 16
    Hualu Yang, Marcia Petrini, Effect of cognitive behavior therapy on sleep disorder in Parkinson's disease in China: A pilot study, Nursing & Health Sciences, 2012, 14, 4
  17. 17
    Raman Malhotra, Alon Y. Avidan, Neurodegenerative Disease and REM Behavior Disorder, Current Treatment Options in Neurology, 2012, 14, 5, 474

    CrossRef

  18. 18
    Oscar Bernal-Pacheco, Natlada Limotai, Criscely L. Go, Hubert H. Fernandez, Nonmotor Manifestations in Parkinson Disease, The Neurologist, 2012, 18, 1, 1

    CrossRef

  19. 19
    Maartje Louter, Willemijn C. C. A. Aarden, Joy Lion, Bastiaan R. Bloem, Sebastiaan Overeem, Recognition and diagnosis of sleep disorders in Parkinson’s disease, Journal of Neurology, 2012, 259, 10, 2031

    CrossRef

  20. 20
    Samrat Roychowdhury, Duncan R. Forsyth, Sleep disturbance in Parkinson disease, Journal of Clinical Gerontology and Geriatrics, 2012, 3, 2, 53

    CrossRef

  21. 21
    Elinor Artsy, David C. McCarthy, Shelley Hurwitz, Milena K. Pavlova, Barbara A. Dworetzky, Jong Woo Lee, Use of modafinil in patients with epilepsy, Epilepsy & Behavior, 2012, 23, 4, 405

    CrossRef

  22. 22
    Avrom L. Kurtz, Daniel I. Kaufer, Dementia in Parkinson’s Disease, Current Treatment Options in Neurology, 2011, 13, 3, 242

    CrossRef

  23. 23
    Ariane Park, Mark Stacy, Dopamine-Induced Nonmotor Symptoms of Parkinson's Disease, Parkinson's Disease, 2011, 2011, 1

    CrossRef

  24. 24
    T. Archer, A. Fredriksson, B. Johansson, Exercise alleviates Parkinsonism: clinical and laboratory evidence, Acta Neurologica Scandinavica, 2011, 123, 2
  25. 25
    Claudio L. Bassetti, Nonmotor Disturbances in Parkinson’s Disease, Neurodegenerative Diseases, 2011, 8, 3, 95

    CrossRef

  26. 26
    Mark Stacy, Nonmotor Symptoms in Parkinson's Disease, International Journal of Neuroscience, 2011, 121, S2, 9

    CrossRef

  27. 27
    Daniel Weintraub, David J. Burn, Parkinson's disease: The quintessential neuropsychiatric disorder, Movement Disorders, 2011, 26, 6
  28. 28
    Jeana Frost, Sally Okun, Timothy Vaughan, James Heywood, Paul Wicks, Patient-reported Outcomes as a Source of Evidence in Off-Label Prescribing: Analysis of Data From PatientsLikeMe, Journal of Medical Internet Research, 2011, 13, 1, e6

    CrossRef

  29. 29
    Santiago Perez-Lloret, María Verónica Rey, Luca Ratti, Olivier Rascol, Pramipexole for the treatment of early Parkinson’s disease, Expert Review of Neurotherapeutics, 2011, 11, 7, 925

    CrossRef

  30. 30
    Raja Mehanna, William G Ondo, Sleep problems in Parkinson’s disease patients, Neurodegenerative Disease Management, 2011, 1, 4, 307

    CrossRef

  31. 31
    George Zhong, Sharon Linda Naismith, Naomi Louise Rogers, Simon John Geoffrey Lewis, Sleep–wake disturbances in common neurodegenerative diseases: A closer look at selected aspects of the neural circuitry, Journal of the Neurological Sciences, 2011, 307, 1-2, 9

    CrossRef

  32. 32
    Klaus Seppi, Daniel Weintraub, Miguel Coelho, Santiago Perez-Lloret, Susan H. Fox, Regina Katzenschlager, Eva-Maria Hametner, Werner Poewe, Olivier Rascol, Christopher G. Goetz, Cristina Sampaio, The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease, Movement Disorders, 2011, 26, S3
  33. 33
    Mary Ann Thenganatt, Steven J. Frucht, Treatment Options for Sleep Dysfunction in Parkinson’s Disease, Current Treatment Options in Neurology, 2011, 13, 5, 473

    CrossRef

  34. 34
    María Angustias Portela, Carlos Centeno, Álvaro Sanz Rubiales, Uso de modafinilo en astenia por cáncer avanzado, Medicina Paliativa, 2011, 18, 4, 149

    CrossRef

  35. 35
    R. Robert Auger, Bradley F. Boeve, Sleep Disorders, 2011,

    CrossRef

  36. 36
    Aleksandar Videnovic, Cynthia L. Comella, Sleep Disorders, 2011,

    CrossRef

  37. 37
    Sudhansu Chokroverty, Pasquale Montagna, Medicina de los Trastornos del Sueño, 2011,

    CrossRef

  38. 38
    Michelle T. Cao, Charles F.P. George, Christian Guilleminault, Principles and Practice of Sleep Medicine, 2011,

    CrossRef

  39. 39
    Santiago Perez-Lloret, Olivier Rascol, Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease, CNS Drugs, 2010, 24, 11, 941

    CrossRef

  40. 40
    Martin McElhiney, Judith Rabkin, Wilfred Van Gorp, Richard Rabkin, Modafinil effects on cognitive function in HIV+ patients treated for fatigue: A placebo controlled study, Journal of Clinical and Experimental Neuropsychology, 2010, 32, 5, 474

    CrossRef

  41. 41
    Hilary L. Tyne, Joanne Taylor, Gus A. Baker, Malcolm J. Steiger, Modafinil for Parkinson’s disease fatigue, Journal of Neurology, 2010, 257, 3, 452

    CrossRef

  42. 42
    Roberto Ceravolo, Carlo Rossi, Lorenzo Kiferle, Ubaldo Bonuccelli, Nonmotor symptoms in Parkinson’s disease: the dark side of the moon, Future Neurology, 2010, 5, 6, 851

    CrossRef

  43. 43
    Guo Tao, Zhao Longshan, Wu Kehua, Xia Dongya, Lu Wei, Guan Zheng, Deng Chenhui, Population Pharmacokinetics of Modafinil in Chinese Han, Mongolian, Korean, Uygur, and Hui Healthy Subjects Determined by Nonlinear Mixed-Effects Modeling, Therapeutic Drug Monitoring, 2010, 1

    CrossRef

  44. 44
    P. Derkinderen, Quelles pistes pharmacologiques non-dopaminergiques pour le traitement de la maladie de Parkinson ?, Revue Neurologique, 2010, 166, 10, 811

    CrossRef

  45. 45
    Birgit Högl, Isabelle Arnulf, Cynthia Comella, Joaquim Ferreira, Alex Iranzo, Barbara Tilley, Claudia Trenkwalder, Werner Poewe, Olivier Rascol, Cristina Sampaio, Glenn T. Stebbins, Anette Schrag, Christopher G. Goetz, Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations, Movement Disorders, 2010, 25, 16
  46. 46
    Matthew Menza, Roseanne DeFronzo Dobkin, Humberto Marin, Karina Bienfait, Sleep disturbances in Parkinson's disease, Movement Disorders, 2010, 25, S1
  47. 47
    John Y. Fang, UPDATE ON THE MEDICAL MANAGEMENT OF PARKINSON DISEASE, CONTINUUM: Lifelong Learning in Neurology, 2010, 16, 96

    CrossRef

  48. 48
    Sleep Medicine in Clinical Practice, Second Edition, 2010,

    CrossRef

  49. 49
    Daniel Weintraub, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  50. 50
    Jolyon Meara, Brocklehurst's Textbook of Geriatric Medicine and Gerontology, 2010,

    CrossRef

  51. 51
    David John Burn, MOVEMENT DISORDERS 4, 2010,

    CrossRef

  52. 52
    K. Ray Chaudhuri, Per Odin, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  53. 53
    Leslie Blackhall, Gina Petroni, Jianfen Shu, Lora Baum, Elena Farace, A Pilot Study Evaluating the Safety and Efficacy of Modafinil for Cancer-Related Fatigue, Journal of Palliative Medicine, 2009, 12, 5, 433

    CrossRef

  54. 54
    Matthias Löhle, Alexander Storch, Heinz Reichmann, Beyond tremor and rigidity: non-motor features of Parkinson’s disease, Journal of Neural Transmission, 2009, 116, 11, 1483

    CrossRef

  55. 55
    Harrison G. Bloom, Imran Ahmed, Cathy A. Alessi, Sonia Ancoli-Israel, Daniel J. Buysse, Meir H. Kryger, Barbara A. Phillips, Michael J. Thorpy, Michael V. Vitiello, Phyllis C. Zee, Evidence-Based Recommendations for the Assessment and Management of Sleep Disorders in Older Persons, Journal of the American Geriatrics Society, 2009, 57, 5
  56. 56
    Joseph H. Friedman, Fatigue in Parkinson’s disease patients, Current Treatment Options in Neurology, 2009, 11, 3, 186

    CrossRef

  57. 57
    Mark Stacy, Medical Treatment of Parkinson Disease, Neurologic Clinics, 2009, 27, 3, 605

    CrossRef

  58. 58
    David Orlikowski, Sylvie Chevret, Maria Antonia Quera-Salva, Pascal Laforêt, Frédéric Lofaso, Annie Verschueren, Jean Pouget, Bruno Eymard, Djillali Annane, Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: A multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial, Clinical Therapeutics, 2009, 31, 8, 1765

    CrossRef

  59. 59
    Judith G. Rabkin, Paul H. Gordon, Martin McElhiney, Richard Rabkin, Sheena Chew, Hiroshi Mitsumoto, Modafinil treatment of fatigue in patients with ALS: A placebo-controlled study, Muscle & Nerve, 2009, 39, 3
  60. 60
    Dag Aarsland, Laura Marsh, Anette Schrag, Neuropsychiatric symptoms in Parkinson's disease, Movement Disorders, 2009, 24, 15
  61. 61
    Ariane Park, Mark Stacy, Non-motor symptoms in Parkinson’s disease, Journal of Neurology, 2009, 256, S3, 293

    CrossRef

  62. 62
    Jau-Shin Lou, Physical and Mental Fatigue in Parkinsonʼs Disease, Drugs & Aging, 2009, 26, 3, 195

    CrossRef

  63. 63
    I. G. Silkis, Search for approaches to correction of daytime sleepiness induced by dopaminergic drugs during treatment of Parkinson’s disease: Neurochemical aspects, Neurochemical Journal, 2009, 3, 3, 221

    CrossRef

  64. 64
    Renee Monderer, Michael Thorpy, Sleep disorders and daytime sleepiness in Parkinson’s disease, Current Neurology and Neuroscience Reports, 2009, 9, 2, 173

    CrossRef

  65. 65
    Jau-Shin Lou, Diana M. Dimitrova, Byung S. Park, Sarah C. Johnson, Ryan Eaton, Grace Arnold, John G. Nutt, Using Modafinil to Treat Fatigue in Parkinson Disease, Clinical Neuropharmacology, 2009, 32, 6, 305

    CrossRef

  66. 66
    Sudhansu Chokroverty, Pasquale Montagna, Sleep Disorders Medicine, 2009,

    CrossRef

  67. 67
    Kelvin L. Chou, Adverse Events from the Treatment of Parkinson's Disease, Neurologic Clinics, 2008, 26, 3, 65

    CrossRef

  68. 68
    Raminder Kumar, Approved and Investigational Uses of Modafinil, Drugs, 2008, 68, 13, 1803

    CrossRef

  69. 69
    Daniel D. Truong, Roongroj Bhidayasiri, Erik Wolters, Management of non-motor symptoms in advanced Parkinson disease, Journal of the Neurological Sciences, 2008, 266, 1-2, 216

    CrossRef

  70. 70
    Tanya Simuni, Kapil Sethi, Nonmotor manifestations of Parkinson's disease, Annals of Neurology, 2008, 64, S2
  71. 71
    P. Xu, H.-D. Li, B.-K. Zhang, Y.-W. Xiao, H.-Y. Yuan, Y.-G. Zhu, Pharmacokinetics and tolerability of modafinil tablets in Chinese subjects, Journal of Clinical Pharmacy and Therapeutics, 2008, 33, 4
  72. 72
    Cynthia L. Comella, Sleep Disorders in Parkinson's Disease, Sleep Medicine Clinics, 2008, 3, 3, 325

    CrossRef

  73. 73
    Cynthia L. Comella, Sleep disorders in Parkinson’s disease, Current Treatment Options in Neurology, 2008, 10, 3, 215

    CrossRef

  74. 74
    C. Monaca, Somnolence et syndromes parkinsoniens, Revue Neurologique, 2008, 164, 12, F253

    CrossRef

  75. 75
    Ubaldo Bonuccelli, Roberto Ceravolo, The safety of dopamine agonists in the treatment of Parkinson's disease, Expert Opinion on Drug Safety, 2008, 7, 2, 111

    CrossRef

  76. 76
    Sanneke A.M. van Vliet, Raymond A.P. Vanwersch, Marjan J. Jongsma, Berend Olivier, Ingrid H.C.H.M. Philippens, Therapeutic effects of Δ9-THC and modafinil in a marmoset Parkinson model, European Neuropsychopharmacology, 2008, 18, 5, 383

    CrossRef

  77. 77
    Elemer Szabadi, Ebony Samuels, Sleep Disorders, 2008,

    CrossRef

  78. 78
    Joseph H. Friedman, Richard G. Brown, Cynthia Comella, Carol E. Garber, Lauren B. Krupp, Jau-Shin Lou, Laura Marsh, Lillian Nail, Lisa Shulman, C. Barr Taylor, Fatigue in Parkinson's disease: A review, Movement Disorders, 2007, 22, 3
  79. 79
    Leora L Borek, Kelvin L Chou, Joseph H Friedman, Management of the behavioral aspects of Parkinson’s disease, Expert Review of Neurotherapeutics, 2007, 7, 6, 711

    CrossRef

  80. 80
    Aleksandar Videnovic, Tanya Simuni, Managing sleep disorders in Parkinson’s disease, Aging Health, 2007, 3, 1, 49

    CrossRef

  81. 81
    Theresa A. Zesiewicz, Robert A. Hauser, MEDICAL TREATMENT OF MOTOR AND NONMOTOR FEATURES OF PARKINSON'S DISEASE, CONTINUUM: Lifelong Learning in Neurology, 2007, 13, 12

    CrossRef

  82. 82
    Kari A. Martin, Lois E. Krahn, Vijayan Balan, Marianne J. Rosati, Modafinil’s Use in Combating Interferon-Induced Fatigue, Digestive Diseases and Sciences, 2007, 52, 4, 893

    CrossRef

  83. 83
    Jyh-Gong Gabriel Hou, Eugene C Lai, Non-motor Symptoms of Parkinson's Disease, International Journal of Gerontology, 2007, 1, 2, 53

    CrossRef

  84. 84
    Sharon Muzerengi, Donatella Contrafatto, K. Ray Chaudhuri, Non-motor symptoms: Identification and management, Parkinsonism & Related Disorders, 2007, 13, S450

    CrossRef

  85. 85
    Ubaldo Bonuccelli, Nicola Pavese, Role of dopamine agonists in Parkinson’s disease: an update, Expert Review of Neurotherapeutics, 2007, 7, 10, 1391

    CrossRef

  86. 86
    Thomas Freedom, Sleep and Parkinson’s Disease, Disease-a-Month, 2007, 53, 5, 275

    CrossRef

  87. 87
    Cynthia L. Comella, Sleep disorders in Parkinson's disease: An overview, Movement Disorders, 2007, 22, S17
  88. 88
    Charlene Hoffman Snyder, Charles H. Adler, The patient with Parkinson’s disease: Part I–Treating the motor symptoms; Part II–Treating the nonmotor symptoms, Journal of the American Academy of Nurse Practitioners, 2007, 19, 4
  89. 89
    M. Emre, Treatment of dementia associated with Parkinson's disease, Parkinsonism & Related Disorders, 2007, 13, S457

    CrossRef

  90. 90
    Claudia Trenkwalder, Birgit Högl, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  91. 91
    Robert Rodnitzky, Sleep Disorders and Neurologic Diseases, Second Edition, 2007,

    CrossRef

  92. 92
    Murat Emre, Parkinson's Disease and Related Disorders, Part I, 2007,

    CrossRef

  93. 93
    Danielle Turner, A review of the use of modafinil for attention-deficit hyperactivity disorder, Expert Review of Neurotherapeutics, 2006, 6, 4, 455

    CrossRef

  94. 94
    Sanneke A. M. van Vliet, Marjan J. Jongsma, Raymond A. P. Vanwersch, Berend Olivier, Ingrid H. C. H. M. Philippens, Behavioral effects of modafinil in marmoset monkeys, Psychopharmacology, 2006, 185, 4, 433

    CrossRef

  95. 95
    Caroline H Williams-Gray, Thomas Foltynie, Simon J G Lewis, Roger A Barker, Cognitive Deficits and Psychosis in Parkinson???s Disease, CNS Drugs, 2006, 20, 6, 477

    CrossRef

  96. 96
    E. R. Samuels, R. H. Hou, R. W. Langley, E. Szabadi, C. M. Bradshaw, Comparison of pramipexole and amisulpride on alertness, autonomic and endocrine functions in healthy volunteers, Psychopharmacology, 2006, 187, 4, 498

    CrossRef

  97. 97
    Ubaldo Bonuccelli, Nicola Pavese, Dopamine agonists in the treatment of Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 1, 81

    CrossRef

  98. 98
    John C Morgan, Kapil D Sethi, Emerging drugs for Parkinson’s disease, Expert Opinion on Emerging Drugs, 2006, 11, 3, 403

    CrossRef

  99. 99
    David B. Rye, Excessive daytime sleepiness and unintended sleep in Parkinson’s disease, Current Neurology and Neuroscience Reports, 2006, 6, 2, 169

    CrossRef

  100. 100
    Amos D. Korczyn, Management of sleep problems in Parkinson's disease, Journal of the Neurological Sciences, 2006, 248, 1-2, 163

    CrossRef

  101. 101
    Mark J. Millan, Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application, Pharmacology & Therapeutics, 2006, 110, 2, 135

    CrossRef

  102. 102
    Sharon Muzerengi, Helen Lewis, Mark Edwards, Emma Kipps, Anuj Bahl, Pablo Martinez-Martin, K Ray Chaudhuri, Non-motor symptoms in Parkinson's disease: an underdiagnosed problem, Aging Health, 2006, 2, 6, 967

    CrossRef

  103. 103
    Theresa A Zesiewicz, Kelly L Sullivan, Robert A Hauser, Nonmotor symptoms of Parkinson’s disease, Expert Review of Neurotherapeutics, 2006, 6, 12, 1811

    CrossRef

  104. 104
    Alex Iranzo, Parkinson's Disease and Sleepiness, Sleep Medicine Clinics, 2006, 1, 1, 127

    CrossRef

  105. You have free access to this content105
    K. Ming Chan, Fay J. Strohschein, David Rydz, Amyn Allidina, Ashfaq Shuaib, Chris F. Westbury, Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients, Muscle & Nerve, 2006, 33, 1
  106. 106
    R. H. Hou, C. Freeman, R. W. Langley, E. Szabadi, C. M. Bradshaw, Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers, Psychopharmacology, 2005, 181, 3, 537

    CrossRef

  107. 107
    Isabelle Arnulf, Excessive daytime sleepiness in parkinsonism, Sleep Medicine Reviews, 2005, 9, 3, 185

    CrossRef

  108. 108
    Jonathan RL Schwartz, Modafinil: expanded options for the treatment of excessive sleepiness, Therapy, 2005, 2, 2, 191

    CrossRef

  109. 109
    Jonathan RL Schwartz, Modafinil: expanded options for the treatment of excessive sleepiness, Therapy, 2005, 2, 2, 191

    CrossRef

  110. 110
    Charles H. Adler, Nonmotor complications in Parkinson's disease, Movement Disorders, 2005, 20, S11
  111. 111
    Michael J. Thorpy, Charles H. Adler, Parkinson's Disease and Sleep, Neurologic Clinics, 2005, 23, 4, 1187

    CrossRef

  112. 112
    Claudia Trenkwalder, Principles and Practice of Sleep Medicine, 2005,

    CrossRef

  113. 113
    Humberto Marin, Roseanne DeFronzo Dobkin, Psychiatric Issues in Parkinson's Disease, 2005,

    CrossRef

  114. 114
    Michio Hirano, Modafinil decreases hypersomnolence and improves mood in patients with myotonic dystrophy, Current Neurology and Neuroscience Reports, 2004, 4, 1, 49

    CrossRef

  115. 115
    Ali Samii, John G Nutt, Bruce R Ransom, Parkinson's disease, The Lancet, 2004, 363, 9423, 1783

    CrossRef

  116. 116
    Joseph H. Friedman, Kelvin L. Chou, Sleep and fatigue in Parkinson's disease, Parkinsonism & Related Disorders, 2004, 10, S27

    CrossRef

  117. 117
    Tanya Simuni, Somnolence and other sleep disorders in Parkinson's disease: the challenge for the practicing neurologist, Neurologic Clinics, 2004, 22, 3, S107

    CrossRef

  118. 118
    Edward C. Lauterbach, The neuropsychiatry of Parkinson's disease and related disorders, Psychiatric Clinics of North America, 2004, 27, 4, 801

    CrossRef

  119. 119
    W. H. Oertel, A. Berardelli, B. R. Bloem, U. Bonuccelli, D. Burn, G. Deuschl, E. Dietrichs, G. Fabbrini, J. J. Ferreira, A. Friedman, P. Kanovsky, V. Kostic, A. Nieuwboer, P. Odin, W. Poewe, O. Rascol, C. Sampaio, M. Schüpbach, E. Tolosa, C. Trenkwalder, Late (Complicated) Parkinson's Disease,
  120. 120
    Mark Stacy, Joseph Jankovic, Overview of the Medical Treatment of the Non-Motor and Non-Dopaminergic Features of Parkinson's Disease,
  121. 121
    P. Jennum, J. Santamaria Cano, C. Bassetti, P. Clarenbach, B. Högl, J. Mathis, R. Poirrier, K. Sonka, E. Svanborg, L. Dolenc Groselj, D. Kaynak, M. Kruger, A. Papavasiliou, Z. Zahariev, Sleep Disorders in Neurodegenerative Disorders and Stroke,
  122. 122
    P. Jennum, J. Santamaria Cano, C. Bassetti, P. Clarenbach, B. Högl, J. Mathis, R. Poirrier, K. Sonka, E. Svanborg, L. Dolenc Grosel, D. Kaynak, M. Kruger, A. Papavasiliou, Z. Zahariev, Sleep Disorders in Neurodegenerative Disorders and Stroke,
  123. 123
    Joaquim Ferreira, Tiago Mestre, Russell M Hewett, Miguel M Coelho, Mário Rosa, Olivier Rascol, Cristina Sampaio, Therapeutic interventions for daytime somnolence in Parkinson's disease, The Cochrane Library,
  124. 124
    Murat Emre, Treatment of Dementia Associated with Parkinson's Disease,